Sullivan E, Ruegger M, Dunne I, Sutaria N, Towers WF (2023) Comparison of effectiveness and safety of sodium polystyrene sulfonate and sodium zirconium cyclosilicate for treatment of hyperkalemia in hospitalized patients. Am J Health-Syst Pharm 80:1238–1246

Article  PubMed  CAS  Google Scholar 

Trevisan M, Clase CM, Evans M, Popov T, Ludvigsson JF, Sjölander A, Carrero JJ (2022) Patterns of chronic and transient hyperkalaemia and clinically important outcomes in patients with chronic kidney disease. Clin Kidney J 15:153–161

Article  PubMed  CAS  Google Scholar 

Muhlestein JB, Kammerer J, Bair TL, Knowlton KU, Le VT, Anderson JL, Lappé DL, May HT (2022) Real-world clinical burden and economic assessment associated with hyperkalaemia in a large integrated healthcare system: a retrospective analysis. BMC Prim Care 23:65

Article  PubMed  PubMed Central  Google Scholar 

Grobbee DE, Filippatos G, Desai NR, Coats AJS, Pinto F, Rosano GMC, Cleland JGF, Kammerer J, de Arellano AR (2024) Epidemiology and risk factors for hyperkalaemia in heart failure. ESC Heart Fail 11:1821–1840

Article  PubMed  PubMed Central  Google Scholar 

Rakisheva A, Marketou M, Klimenko A, Troyanova-Shchutskaia T, Vardas P (2020) Hyperkalemia in heart failure: foe or friend? Clin Cardiol 43:666–675

Article  PubMed  PubMed Central  Google Scholar 

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, ESC Scientific Document Group (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599–3726

Article  PubMed  CAS  Google Scholar 

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. J Am Coll Cardiol 79:1757–1780

Article  PubMed  Google Scholar 

An J, Zhou H, Ni L, Harrision TN, Wei R, Agiro A, Brahmbhatt YG, Oluwatosin Y, Schilling CG, Sim JJ (2023) Discontinuation of renin-angiotensin-aldosterone system inhibitors secondary to hyperkalemia translates into higher cardiorenal outcomes. Am J Nephrol 54:258–267

Article  PubMed  CAS  Google Scholar 

Jonsson Holmdahl A, Wessberg G, Norberg H, Söderström A, Valham F, Bergdahl E, Lindmark K (2022) Motives, frequency, predictors and outcomes of MRA discontinuation in a real-world heart failure population. Open Heart 9:e002022

Article  PubMed  PubMed Central  Google Scholar 

Nishihara T, Tokitsu T, Sueta D, Takae M, Oike F, Fujisue K, Usuku H, Takashio S, Hanatani S, Kanazawa H, Arima Y, Sakamoto K, Izumiya Y, Yamabe H, Kaikita K, Yamamoto E, Tsujita K (2018) Serum potassium and cardiovascular events in heart failure with preserved left ventricular ejection fraction patients. Am J Hypertens 31:1098–1105

Article  PubMed  CAS  Google Scholar 

Muhlestein JB, Kammerer J, Bair TL, Knowlton KU, Le VT, Anderson JL, Lappé DL, May HT (2021) Frequency and clinical impact of hyperkalaemia within a large, modern, real-world heart failure population. ESC Heart Fail 8:691–696

Article  PubMed  Google Scholar 

Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Henderson AD, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Abidin IZ, Alcocer-Gamba MA, Atherton JJ, Bauersachs J, Chang-Sheng M, Chiang CE, Chioncel O, Chopra V, Comin-Colet J, Filippatos G, Fonseca C, Gajos G, Goland S, Goncalvesova E, Kang S, Katova T, Kosiborod MN, Latkovskis G, Lee APW, Linssen GCM, Llamas-Esperón G, Mareev V, Martinez FA, Melenovský V, Merkely B, Nodari S, Petrie MC, Saldarriaga CI, Saraiva JFK, Sato N, Schou M, Sharma K, Troughton R, Udell JA, Ukkonen H, Vardeny O, Verma S, von Lewinski D, Voronkov L, Yilmaz MB, Zieroth S, Lay-Flurrie J, van Gameren I, Amarante F, Kolkhof P, Viswanathan P, FINEARTS-HF Committees and Investigators (2024) Finerenone in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med 391:1475–1485

Article  PubMed  CAS  Google Scholar 

Kitai T, Kohsaka S, Kato T, Kato E, Sato K, Teramoto K, Yaku H, Akiyama E, Ando M, Izumi C, Ide T, Iwasaki YK, Ohno Y, Okumura T, Ozasa N, Kaji S, Kashimura T, Kitaoka H, Kinugasa Y, Kinugawa S, Toda K, Nagai T, Nakamura M, Hikoso S, Minamisawa M, Wakasa S, Anchi Y, Oishi S, Okada A, Obokata M, Kagiyama N, Kato NP, Kohno T, Sato T, Shiraishi Y, Tamaki Y, Tamura Y, Nagao K, Nagatomo Y, Nakamura N, Nochioka K, Nomura A, Nomura S, Horiuchi Y, Mizuno A, Murai R, Inomata T, Kuwahara K, Sakata Y, Tsutsui H, Kinugawa K, Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group (2025) JCS/JHFS 2025 guideline on diagnosis and treatment of heart failure. Circ J 89:1278–1444

Article  PubMed  Google Scholar 

Sinnathamby ES, Banh KT, Barham WT, Hernandez TD, De Witt AJ, Wenger DM, Klapper VG, McGregor D, Paladini A, Ahmadzadeh S, Shekoohi S, Kaye AD, Varrassi G (2024) Hyperkalemia: pharmacotherapies and clinical considerations. Cureus 16:e52994

PubMed  PubMed Central  Google Scholar 

Kashihara N, Kohsaka S, Kanda E, Okami S, Yajima T (2019) Hyperkalemia in real-world patients under continuous medical care in Japan. Kidney Int Rep 4:1248–1260

Article  PubMed  PubMed Central  Google Scholar 

Kosiborod M, Rasmussen HS, Lavin P, Qunibi WY, Spinowitz B, Packham D, Roger SD, Yang A, Lerma E, Singh B (2014) Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial. JAMA 312:2223–2233

Article  PubMed  Google Scholar 

Zhuo M, Kim SC, Patorno E, Paik JM (2022) Risk of hospitalization for heart failure in patients with hyperkalemia treated with sodium zirconium cyclosilicate versus Patiromer. J Card Fail 28:1414–1423

Article  PubMed  Google Scholar 

Kosiborod MN, Cherney DZI, Desai AS, Testani JM, Verma S, Chinnakondepalli K, Dolling D, Patel S, Dahl M, Eudicone JM, Friberg L, Ouwens M, Antunes MO, Connelly KA, Madrini V, Kuthi L, Lala A, Lorenzo M, Guimarães PO, Marcos MC, Merkely B, Nuñez J, Squire I, Václavík J, Wranicz J, Petrie MC (2025) Sodium zirconium cyclosilicate for management of hyperkalemia during spironolactone optimization in patients with heart failure. J Am Coll Cardiol 85:971–984

Article  PubMed  CAS  Google Scholar 

Anker SD, Kosiborod M, Zannad F, Piña IL, McCullough PA, Filippatos G, van der Meer P, Ponikowski P, Rasmussen HS, Lavin PT, Singh B, Yang A, Deedwania P (2015) Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial. Eur J Heart Fail 17:1050–1056

Article  PubMed  CAS  Google Scholar 

Tardif J-C, Rouleau J, Chertow GM, Al-Shurbaji A, Lisovskaja V, Gustavson S, Zhao Y, Bouabdallaoui N, Desai AS, Chernyavskiy A, Evsina M, Merkely B, McMurray JJV, Pfeffer MA (2023) Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure. ESC Heart Fail 10:1066–1076

Article  PubMed  Google Scholar 

Nagai K, Tanaka T, Kodaira N, Kimura S, Takahashi Y, Nakayama T (2020) Data resource profile: JMDC claims databases sourced from medical institutions. J Gen Fam Med 21:211–218

Article  PubMed  PubMed Central  Google Scholar 

Anno T, Fukasawa T, Shinozaki T, Takeuchi M, Yoshida S, Kawakami K (2024) Impact of early resumption of oral anticoagulation on recurrence after surgery for chronic subdural hematoma in patients with atrial fibrillation: a target trial emulation. Pharmacoepidemiol Drug Saf 33:e70063

Article  PubMed  CAS  Google Scholar 

Masuda S, Fukasawa T, Otsuki B, Murata K, Shimizu T, Sono T, Honda S, Shima K, Sakamoto M, Matsuda S, Kawakami K (2024) Unchanged incidence of major adverse events amidst rising surgical interventions for osteoporotic vertebral fractures, 2015–2021. Arch Osteoporos 19:71

Article  PubMed  Google Scholar 

Schneeweiss S, Patorno E (2021) Conducting real-world evidence studies on the clinical outcomes of diabetes treatments. Endocr Rev 42:658–690

Article  PubMed  PubMed Central  Google Scholar 

Masuda S, Fukasawa T, Matsuda S, Yoshida S, Kawakami K (2024) Comparative effectiveness and cardiovascular safety of Romosozumab versus teriparatide in patients with osteoporosis: a population-based cohort study. Osteoporos Int 35:2165–2174

Article  PubMed  CAS  Google Scholar 

Montford JR, Linas S (2017) How dangerous is hyperkalemia? J Am Soc Nephrol 28:3155–3165

Article  PubMed  PubMed Central  CAS  Google Scholar 

Masuda S, Fukasawa T, Matsuda S, Kawakami K (2025) Cardiovascular safety and fracture prevention effectiveness of denosumab versus oral bisphosphonates in patients receiving dialysis: a target trial emulation. Ann Intern Med 178:167–176

Article  PubMed  Google Scholar 

Tada H, Kaneko H, Suzuki Y, Okada A, Takeda N, Fujiu K, Morita H, Ako J, Node K, Takeji Y, Takamura M, Yasunaga H, Komuro I (2024) Familial hypercholesterolemia is related to cardiovascular disease, heart failure and atrial fibrillation. Results from a population-based study. Eur J Clin Invest 54:e14119